Rivamer

Rivamer 1.5 Capsule may take as long as 12 weeks to begin working. Response to the medicine differs from person to person. The clinical benefits of Rivamer 1.5 Capsule should be assessed regularly. If after 12 weeks of treatment the symptoms do not improve, Rivamer 1.5 Capsule should be stopped.

Always take the medicine as directed by your doctor. Usually, Rivamer 1.5 Capsule is prescribed to be taken twice a day, in the morning and evening, with food. Swallow the whole capsule with water and do not open or crush the capsule. Check with your doctor or pharmacist if you are not sure.

Yes, antacids can be taken while taking Rivamer 1.5 Capsule as they do not interfere with the working of Rivamer 1.5 Capsule. Moreover, Rivamer 1.5 Capsule may cause increased acid secretion in the stomach in some patients. Your doctor may prescribe an antacid to relieve this acidity.

Taking more than the recommended doses of Rivamer 1.5 Capsule may cause diarrhea, abdominal pain, dizziness, tremor, headache, sleepiness, hallucinations, and malaise. Higher doses may also cause confusion, increased sweating, and an increase in blood pressure. In case you take an overdose of Rivamer 1.5 Capsule, seek immediate medical attention.

Yes, Rivamer 1.5 Capsule can cause drowsiness or sleepiness, especially at the start of treatment or when increasing the dose. If you feel dizzy or sleepy, do not drive, use machines or perform any tasks that require your attention.

You should not stop or change the dose of Rivamer 1.5 Capsule without consulting your doctor. However, if treatment is interrupted for more than three days, then do not take the medicine and consult your doctor. The doctor will re-initiate the treatment with a low dose twice a day. The dose can then be increased gradually as was done previously.

Yes, Rivamer 1.5 Capsule can cause hallucinations. However, hallucinations are reported very rarely with the use of Rivamer 1.5 Capsule, which means they occur in very few people. It may usually occur shortly after dose increase.